Press

TORONTO, July 27, 2025 /PRNewswire/ — The Alzheimer’s Association® will present 10 scientific awards at the Alzheimer’s Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy achievements and innovative contributions to the field of Alzheimer’s disease and dementia science. “The Alzheimer’s Association envisions a world without Alzheimer’s and all other dementia, and these leaders […]

TORONTO, July 27, 2025 /PRNewswire/ — The Alzheimer’s Association® honored the Fred and Barbara Erb Family Foundation with the Jerome H. Stone Philanthropy Award for Alzheimer’s Research at the Alzheimer’s Association International Conference ® 2025 (AAIC®) for their deep and unwavering contributions to advancing progress in Alzheimer’s science. Fred A. Erb grew his family’s firm

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  The investigation concerns whether Jasper and certain of its officers and/or directors have engaged in securities fraud or other unlawful

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”)(NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number,

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Mereo and certain of its officers and/or directors have engaged in securities fraud

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  The J.M. Smucker Company (“Smucker” or the “Company”) (NYSE: SJM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Smucker and certain of its officers and/or directors have engaged in securities fraud

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zeo Energy Corp. (“Zeo” or the “Company”) (NASDAQ: ZEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Zeo and certain of its officers and/or directors have engaged in securities fraud or other unlawful